Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Emergent BioSolutions is a global life sciences company dedicated to developing, manufacturing, and delivering solutions that protect or enhance life by addressing public health threats. The company's portfolio includes vaccines and therapeutics for infectious diseases, chemical, biological, radiological, and nuclear (CBRN) threats, and emerging health crises. Emergent BioSolutions collaborates with governments, NGOs, and commercial partners worldwide to provide preparedness and response solutions for critical health emergencies, aiming to make a meaningful impact on global health security.
Serves as the global corporate center, housing executive leadership, strategic planning, finance, legal, and other core administrative functions supporting the company's worldwide operations.
Located in a prominent life sciences and biotechnology corridor in Montgomery County, Maryland. The facility is a modern office building designed to support corporate operations.
A mission-driven environment focused on addressing critical public health challenges. The culture emphasizes scientific innovation, collaboration across diverse teams, and a strong commitment to quality, compliance, and ethical conduct in service of its public health mission.
The headquarters is central to Emergent BioSolutions' strategic direction and operational oversight, coordinating its global network of research, development, and manufacturing sites. Its location provides access to a rich talent pool and proximity to key U.S. government agencies.
Emergent BioSolutions maintains a significant global presence with key operations spanning North America (United States and Canada) and Europe (including Switzerland and the UK). Core functions supported globally include research and development, small- and large-scale manufacturing of vaccines and therapeutics, quality assurance, regulatory affairs, and commercial distribution. The company's products are supplied to governments and healthcare providers worldwide to address public health threats and prepare for health emergencies.
400 Professional Drive
Gaithersburg
MD
USA
Address: 5901 East Lombard Street, Baltimore, MD 21224, USA
Strengthens U.S. domestic manufacturing capabilities for essential public health products and supports national biodefense preparedness efforts.
Address: 3500 N. Martin Luther King Jr. Blvd., Lansing, MI 48906, USA
Serves as a cornerstone of U.S. preparedness against specific biothreats like smallpox and anthrax, with specialized manufacturing capabilities.
Address: 155 Innovation Drive, Winnipeg, Manitoba R3T 5Y3, Canada
Supports the Canadian and international markets with specialized biopharmaceutical products and serves as a key R&D and manufacturing hub within Canada for Emergent.
Address: Rehhagstrasse 79, 3018 Bern, Switzerland
Provides essential travel vaccines for Europe and other international markets, contributing to global health and disease prevention for travelers.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Emergent BioSolutions' leadership includes:
Emergent BioSolutions has been backed by several prominent investors over the years, including:
Emergent BioSolutions has undergone a significant leadership transformation over the past 12 months (approx. May 2023 - May 2024), appointing a new CEO, CFO, COO, and General Counsel, among other key leadership roles. This signals a period of strategic renewal and focus for the company.
Discover the tools Emergent BioSolutions uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Emergent BioSolutions commonly uses the '@ebsi.com' email domain. Based on publicly available information and common corporate structures, a likely format involves the employee's last name followed by their first initial.
[lastname][firstinitial]@ebsi.com
Format
papaj@ebsi.com
Example
75%
Success rate
Emergent BioSolutions Investor Relations • May 7, 2024
Emergent BioSolutions announced total revenues of $165.1 million for Q1 2024. The company highlighted progress in its core products and CDMO services, and reaffirmed its commitment to strengthening its financial foundation and executing its strategic plan under new leadership....more
Emergent BioSolutions Investor Relations • April 23, 2024
Emergent BioSolutions announced a contract valued at approximately $75 million by the U.S. Department of Health and Human Services (HHS) to supply Ebanga™, a licensed therapeutic for Ebola virus disease. This contract supports U.S. preparedness efforts....more
Emergent BioSolutions Investor Relations • February 21, 2024
Emergent BioSolutions announced the appointment of Joseph C. Papa as President and CEO, and a member of the Board of Directors, effective February 21, 2024. Mr. Papa brings over 35 years of experience in the healthcare industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Emergent BioSolutions, are just a search away.